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Recently, a novel type of dendritic antigen-presenting
cell has been identified in the dermis of normal human
and mouse skin. These dermal dendritic cells (DDC)
occur in higher numbers than epidermal Langerhans
cells, represent a distinct differentiation pathway of dend-
ritic cells, and are as potent as Langerhans cells in the
activation of superantigen specific T cells. As yet, nothing
is known about their capacity to take up, process, and
present soluble protein antigens. We used the model of
tetanus toxoid (TT) driven T cell proliferation to address
these questions. To test for active internalization of TT
protein, gold labeled TT was incubated with Langerhans
cells and DDC and could be traced to multivesicular
endo-lysosomal compartments. DDC internalize TT
through a receptor-mediated, clathrin-independent path-
way, whereas Langerhans cells predominantly use macro-
pinocytosis. To verify that DDC process TT by the
exogenous pathway of antigen presentation, we pulsed
DDC with TT protein or TT peptide after preincubation
Dendritic cells (DC) belong to a family of antigen-presenting cells (APC) that are located in the T celldependent area of lymphoid tissues and at the barrierzones where antigen entry into the human bodythrough the skin, lung, and gut may take place. The
best studied DC in the human system is the Langerhans cell, located
in a suprabasal position in human and murine epidermis (Stingl and
Bergstresser, 1995). Recently, the dermis has been appreciated as an
important immunoreactive site (Streilein, 1993). The understanding of
components of the dermal immune system may be important not only
for most inflammatory and neoplastic skin diseases, but also for the
understanding of mechanisms involved in anti-tumor vaccination
(Gross, 1943). A new member of the DC family has been described
in a perivascular location at the strategic dermal interface between the
blood supply and the epidermis (Headington, 1986; Lenz et al, 1993;
Meunier et al, 1993; Nestle et al, 1993; Sepulveda-Merrill et al,
1994). Recent evidence indicates a role for dermal DC in contact
hypersensitivity reactions (Streilein, 1989; Tse and Cooper, 1990)
and in diseases such as psoriasis (Nestle et al, 1994), cutaneous
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with chloroquine. Preincubation with chloroquine dimin-
ished the capacity of DDC to induce TT protein specific
T cell proliferation (70–80%), but was not effective to
suppress TT peptide induced T cell responses. DDC were
as potent as Langerhans cells and 5–10 3 more potent
than plastic adherent monocytes in the presentation of
TT to autologous resting T cells. Furthermore, as few as
50 DDC (stimulator:responder ratio of 1:1000) were able
to induce a significant TT specific T cell proliferation.
Because a subpopulation of DDC expresses low levels of
CD1a, a phenotypic marker of Langerhans cells, sorting
of CD1a positive and negative DDC was performed. On
a per cell basis, CD1a positive and negative DDC were
equally potent at mediating TT specific T cell prolifera-
tion. Thus, DDC are able to internalize, process, and
present soluble protein antigens such as TT and may
therefore play an important role in the regulation of
skin immune responses. Key words: antigen-presenting cells/
Langerhans cells/skin immune system/tetanus toxoid. J Invest
Dermatol 110:762–766, 1998
lymphoproliferative disorders (Nestle and Nickoloff, 1994), and derma-
tofibroma (Nestle et al, 1995), as well as Kaposis’ sarcoma (Nickoloff
and Griffith, 1989). More recently, two major pathways of DC
differentiation have been described: one pathway leading to the
development of Langerhans cell-like cells, and a second pathway where
dermal dendritic cells (DDC) seem to be the prototypic cell type
(Caux et al, 1996). Therefore, from the comparative study of Langerhans
cells and DDC one may learn not only about the skin immune system,
but also about the development of DC in general. DDC have
been extensively studied concerning their phenotype and potency for
presentation of bacterial derived superantigens to T cells (Nestle
and Nickoloff, 1995). In contrast, no data are available regarding
phagocytosis, processing, and presentation of more widespread soluble
protein antigens. We have investigated these issues using tetanus toxoid
(TT) as a model antigen because this system is well defined (Demotz
et al, 1989), and circulating TT specific memory T cells are frequent
in the European population. In this study we demonstrate that DDC
effectively take up TT through a receptor mediated nonclathrin
dependent mechanism and transfer it to multilaminar endo-lysosomal
compartments. DDC are as potent as Langerhans cells and more potent
than monocytes in presenting TT protein to autologous CD4 T cells.
Furthermore, on a per cell basis, CD1a positive and negative DDC
subsets have similar capacities of antigen presentation.
MATERIALS AND METHODS
Reagents and antibodies RPMI 1640 (Gibco, Basel, Switzerland) was
supplemented with 10% fetal calf serum (Seromed, Basel, Switzerland), 10 U
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penicillin/streptomycin per ml (Gibco), and 50 µg gentamycin per ml (Gibco).
TT was obtained from the Swiss Serum Institute (Berne, Switzerland). Synthetic
TT derived peptide p30 (TT 947–967; FNNFTVSFWLRVPKVSASHLE) was
obtained from G. Corradin (University of Lausanne, Switzerland). TT-gold
complexes were prepared as already described (Filgueira et al, 1989). Briefly,
colloidal gold particles, 4 nm in size, and TT protein were adjusted at pH 6.1
(isoelectric point) and mixed by stirring. TT-gold complex was purified by
ultracentrifugation (45 min 3 100,000 3 g). Specificity and antigenic properties
of TT-gold were tested using TT specific FC4-EBV cell clone (kindly provided
by A. Lanzavecchia, Basel Institute of Immunology, Switzerland) and TT
specific cell lines (data not shown). TT-gold was found to be equivalent to
soluble TT-protein concerning binding to FC4 cells and activation of TT
specific T cells. Fluoroscein isothiocyanate conjugated isotype controls were
purchased from Becton-Dickinson (Mountain View, CA). CD1a fluoroscein
isothiocyanate (OKT6) antibody was purchased from Ortho Diagnostics (Rari-
tan, NJ).
Cells Normal human skin was obtained from corrective plastic surgery of
breast and abdomen. The inclusion criterion was a recent history of tetanus
vaccination. Split-thickness skin was prepared using a dermatome (Aesculap,
Tuttlingen, Germany) and than incubated in a solution of the bacterial protease
dispase type 2 (Boehringer, Mannheim, Germany) at a final concentration of
1.2 U RPMI 1640 per ml at 4°C overnight. After the incubation period, the
epidermis and dermis could be easily separated. Epidermal and dermal sheets
were then rinsed several times in phosphate-buffered saline, cut into small
pieces (µ1–10 mm), and placed in RPMI 1640 supplemented with 10% fetal
calf serum, in 10 cm tissue culture plates (Merck, Dietikon, Switzerland). After
2–3 d the pieces of tissue were removed and the medium was collected. The
cells that had migrated out of the tissue sections into the medium were spun,
resuspended in 1–2 ml fresh medium, and stained with trypan blue. Cell
viability and cell number was assessed with a hemocytometer. Further enrichment
of DDC and Langerhans cells was achieved through separation with a metrizam-
ide gradient as described (Nestle et al, 1993). Briefly, cells were layered onto
3 ml columns of hypertonic 14.5% metrizamide (Nycomed Pharma AS, Oslo,
Norway) and sedimented at 650 3 g for 10 min at room temperature. Low
density interphase cells were collected and washed in two successive less
hypertonic washes to return cells to isotonicity. DDC expressed high levels of
HLA DR, CD80, CD86, ICAM-1, and CD83 (HB15) in a homogeneous
fashion (data not shown).
For some experiments, metrizamide low density fractions were further
enriched using sterile cell sorting with a FACS Star Plus flow cytometer
(Becton-Dickinson, San Jose, CA). The cells were incubated with a fluoroscein
isothiocyanate conjugated CD1a monoclonal antibody for 30 min on ice and
then washed three times. CD1a positive and negative DDC were obtained after
sorting with a purity of . 95%.
Highly purified resting CD4 positive T cells were obtained by high gradient
magnetic cell sorting using the MACS technique according to the manufacturer’s
procedure (Miltenyi Biotec, Bergisch Gladbach, Germany). Briefly, human
PBMC were enriched by Ficoll-Hypaque gradients. T lymphocytes were
subsequently obtained by a first round of negative selection of HLA-DR
positive cells, followed by positive selection for CD4 positive T cells. T cells
purified by this procedure were always more than 98% CD21/CD41. No
HLA-DR positive T cells were detected by fluorescence-activated cell sorter
(FACS) analysis.
Transmission electron microscopy (TEM) Cells were prefixed with 2.5%
glutaraldehyde 1 0.8% paraformaldehyde, and postfixed with an aqueous
solution of 1% OsO4 containing 1.5% K4(FeCN)6. Subsequently, the specimens
were dehydrated in an alcohol serie and embedded into epon. Ultrathin sections
(µ50 nm) were contrasted with lead citrate and uranyl acetate and examined
with a TEM 420 (Phillips, Eindhoven, the Netherlands).
FACS analysis All antibody dilutions and washes were in phosphate-buffered
saline containing 1% bovine serum albumin (Sigma, Buchs, Switzerland).
Negative controls to rule out nonspecific staining or Fc receptor mediated
binding of antibodies were unrelated monoclonal antibodies of the same isotype.
Cells were aliquoted at 1 3 105 per reaction and all staining was performed
for 25 min at 4°C using the indicated primary reagents. Analysis was performed
by flow cytometry using a FACScan (Becton Dickinson, San Jose, CA) equipped
with a Lysis 2 software.
Proliferation assays Proliferation assays were performed using standard
techniques. Briefly, for the TT specific T cell proliferation assays, gamma
irradiated stimulator cells (3000 rad) were cocultured at the indicated concentra-
tions with 5 3 104 purified CD4 positive T cells in 96 well round-bottom
culture plates (Falcon-Becton-Dickinson, Basel, Switzerland) in 200 µl RPMI
1640 1 10% fetal calf serum for 3 d. Cells were pulsed for the final 18 h of
Figure 1. Ultrastructural analysis of TT uptake and processing in
epidermal Langerhans cells. (A) Overview of Langerhans cell with typical
dendritic membrane processes. (B) No membrane binding of TT was found
but occasionally colloidal gold (4 nm) labeled TT (arrowhead) is found in an
invagination of the surface membrane at the beginning of macropinocytosis.
(C) TT-gold complex (arrowhead) in an endocytotic vesicle near to a Birbeck
granule (arrow). (D) TT-gold complexes (arrowhead) in a tubular (one arrowhead)
and in a multivesicular (two arrowheads) vesicle in the area of the early lysosomal
compartment near to Birbeck granules (arrow).
the incubation period with 1 µCi per well of [3H]TdR (Amersham, Little
Chielfont, U.K.). Values are expressed as the mean cpm 6 SD of triplicate wells.
RESULTS
DDC internalize TT proteins Few data are available regarding
the internalization of soluble protein antigens in human Langerhans
cells (Schuler et al, 1991) and no data are available for antigen uptake
of DDC. To ensure that TT is taken up by the APC, and to visualize
the endocytic and processing pathway, Langerhans cells and DDC
were studied with TEM. For that purpose, the cells were incubated at
culture conditions with gold (4 nm) labeled TT (TT-gold) for different
time periods before they were processed for standard TEM. To
demonstrate that TT-gold was functional, Langerhans cells or DDC
were pulsed for 2 h at 37°C with TT-gold or TT at a concentration
of 10 µg per ml and incubated with autologous CD4 T cells.
Responding T cells proliferated equally well to TT-gold or TT
(data not shown). Langerhans cells and DDC demonstrated a similar
ultramorphology with typical membrane processes or lamellipodia
(Fig 1A, 2A). The cytoplasm contained few lysosomes, many mito-
chondria, profiles of smooth endoplasmatic reticulum, and many
electron-lucent vacuoles. Differences concerning uptake of TT-gold
were detected between Langerhans cells and DDC. DDC bound TT-
gold at their surface membrane before endocytosis took place (Fig 2B).
Also, in the endosomes, TT-gold was found to be bound to the
vesicular membrane (Fig 2C). In contrast, no membrane binding of
TT-gold was found in the case of Langerhans cells, either to the surface
(Fig 1B) or to the endosomal membrane (Fig 1C). In the endosome
of Langerhans cells, TT-gold was laying without contact to the vesicle
membrane free in the vesicular lumen (Fig 1C). In both cell types
endocytic vesicles were uncoated and were of various different sizes
(100–300 nm diameter). Towards the lysosomal compartment, the gold
particle bearing endosomes developed a lamellar or multivesicular
substructure in Langerhans cells (Fig 1D) and DDC (Fig 2D),
which corresponds to the ultramorphology of major histocompatibility
complex (MHC) class II loading compartments.
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Figure 2. Ultrastructural analysis of TT uptake and processing in DDC.
(A) Overview of a DDC with typical dendritic membrane protrusions. (B)
Colloidal gold (4 nm) labeled TT (arrowhead) bound to the surface membrane
of a DDC. (C) TT-gold complexes (arrowhead) are visualized bound to the
membrane of endocytotic vesicles near to the cell surface of a DDC. (D) TT-
gold complexes (arrowhead) are visualized bound to membrane structures in
lamellar vesicles in the area of the early lysosomal compartment.
DDC present TT to autologous T cells We used TT as a model
antigen because many human beings have a history of vaccination for
TT and possess circulating TT specific memory T cells. To test if
DDC present TT to T cells, they were compared with Langerhans
cells and plastic adherent monocytes from the same donor, using
5 3 104 autologous resting CD4 positive T cells as responders. The
T cell responder population was greater than 98% pure and devoid of
accessory cells as confirmed by nonresponsiveness to phytohemaggluti-
nin. Langerhans cells, DDC, and monocytes were pulsed with TT for
2 h at 37°C, washed extensively, and incubated with 5 3 104
responder cells (stimulator:responder ratio of 1:1000, 1:100, and 1:10,
respectively). DDC were as effective as Langerhans cells in presenting
TT to autologous T cells and 5–10 times more potent than monocytes
(Fig 3). Furthermore, as few as 50 DDC were able to induce a
significant TT specific T cell proliferation (. five times background
proliferation).
The exogenous pathway of antigen processing is used by
DDC To verify if DDC process TT by the exogenous (acidic
endosomal) pathway of antigen presentation, we studied the antigen-
processing ability in the presence of chloroquine, a selective inhibitor
of this pathway (Streicher et al, 1984). Langerhans cells and DDC were
pulsed with TT protein (TTprot at 10 µg per ml) or a universally
immunogenic TT peptide p30 (Panina-Bordignon et al, 1989) (TTpept
at 10 ng per ml) in the presence or absence of 300 µM chloroquine.
Five 3 102 APC were then incubated with autologous resting CD4
positive T cells at a stimulator:responder ratio of 1:100 and the
proliferative response was tested. TTpept induced T cell responses
were used to control for chloroquine induced nonspecific suppression
of T cell proliferation. Chloroquine treatment reduced the stimulatory
potency of TTprot pulsed DDC and Langerhans cells significantly
(68% and 64%, respectively) (Fig 4). Using TTpept pulsed APC, no
relevant inhibition of T cell stimulation occurred (DDC, 9%;
Langerhans cells, 27%) (Fig 4). When chloroquine was added to the
APC after antigen pulsing, there was no significant inhibition of T cell
proliferation (data not shown).
Figure 3. Induction of TT specific T cell proliferation by increasing
numbers of stimulator cells. Langerhans cells, DDC, and monocytes (Mono)
were pulsed with TT (10 µg per ml) for 2 h and cultured at 50, 500, and 5000
cells per well in triplicates with 5 3 104 autologous resting CD4 positive T
cells, representing stimulator:responder ratios of 1:1000, 1:100, and 1:10,
respectively. Proliferative responses in these cultures were measured after 3 d.
T cells alone or DDC alone or in the presence of TT incorporated less than
500 cpm. Note the strong stimulatory capacity of Langerhans cells and DDC
relative to monocytes.
Figure 4. Effects of chloroquine on antigen processing. Langerhans cells
and DDC were used as APC and pulsed with TT (TTprot; 10 µg per ml) or
a TT peptide p30 (TTpept at 10 ng per ml) in the presence or absence of
300 µM chloroquine (Chloro). Five 3 102 APC were incubated with 5 3 104
resting CD4 positive T cells (stimulator:responder ratio of 1:100) and proliferative
responses were measured after 3 d. In the presence of chloroquine there was a
68% decrease (16744 6 2210 vs 5511 6 466) in the ability of DDC and a 64%
decrease (14493 6 1031 vs 5445 6 447) in the ability of Langerhans cells to
induce antigen specific T cell proliferation. T cell proliferation in the absence
of antigen was 2122 6 332 for Langerhans cells and 1880 6 322 for DDC.
Comparison of CD1a positive and negative DDC
subsets Subpopulations of CD1a1 and CD1a– DDC have been
described (Meunier et al, 1993; Nestle et al, 1993). To test the possibility
that these subsets differ in their capacity to present antigen, CD1a1 and
CD1a– DDC were differentially sorted on a flow cytometer (purity
. 95%). They were pulsed with TT (10 µg per ml, 2 h at 37°C) and
incubated at different stimulator:responder ratios with autologous
resting CD41 T cells. TT induced T cell proliferation did not
significantly differ between the CD1a1 and CD1a– DDC and was
comparable with unsorted DDC induced T cell proliferation (Fig 5).
This indicates that on a per cell basis, CD1a positive and negative
DDC are equally able to process and present TT protein to autologous
helper T cells.
DISCUSSION
Regional immunity is becoming an increasingly important topic
regarding the peripheral activation and de-activation of circulating T
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Figure 5. TT specific T cell proliferation induced by subpopulations of
DDC. Cell populations were differentially sorted using immunofluorescence
staining for CD1a. CD1a negative and positive, as well as unsorted DDC (50,
500, or 5000 per well in triplicates), were pulsed with TT (10 µg per ml) for
2 h and incubated with 5 3 104 autologous resting CD4 positive T cells,
representing stimulator:responder ratios of 1:1000, 1:100, and 1:10, respectively.
Proliferative responses in these cultures were measured after 3 d. T cells alone
or DDC alone or in the presence of TT incorporated less than 500 cpm. Note
that CD1a positive and negative, as well as unsorted DDC, have similar
capacities in inducing TT specific T cell proliferation.
cells at various tissue sites (Arnold et al, 1992). In this context, activation
of T cells by APC of the dermis that are located at the interface
between blood supply and the skin immune system may play a central
role in vaccination and disease (Streilein, 1993). A new member of
the DC family of APC has been recently isolated from human and
murine dermis and characterized regarding phenotype and T cell
stimulatory capacity (Nestle and Nickoloff, 1995). Interest in the
biology of DDC also stems from the fact that they may be the
physiologic representative of a major DC differentiation pathway (Caux
et al, 1996). No information is currently available concerning uptake,
processing, and presentation to T cells of common soluble protein
antigens by these cells. We have investigated these issues using TT as
a model antigen because this system is well defined (Demotz et al,
1989) and circulating TT specific memory T cells are frequent in the
European population.
Before immunogenic peptides are presented on surface MHC class
II molecules to T cells, protein antigens have to be phagocytosed and
processed intracellularily in the endosomal compartment (Germain,
1994). The processing pathway can be visualized by use of gold labeled
proteins with TEM (Peters et al, 1995). In this study we used gold
labeled TT that had been shown to be functionally active concerning
activation of TT specific T cells by TT pulsed APC. There was
efficient binding of TT-gold to the surface membrane of DDC. The
chemical structure of the molecules binding TT-gold has not been
determined yet. Despite a receptor mediated uptake of TT-gold that
seems to take place in the case of DDC, the endosomal vesicles
were uncoated, indicating a clathrin-independent pinocytic pathway
(Guagliardi et al, 1990; Lamaze and Schmid, 1995). This pathway may
substitute for clathrin-dependent endocytosis in DDC and is currently
under investigation. In contrast, Langerhans cells did not bind TT-
gold to the surface membrane, but were still able to take up TT-gold
efficiently. In Langerhans cells the endosomal vesicles were also
uncoated and displayed typical characteristics of macropinocytosis
(Hewlett et al, 1994). In comparison, Langerhans cells and DDC seem
to use different phagocytosis mechanisms for TT uptake as visualized
by TEM, namely macropinocytosis and receptor mediated phagocytosis,
respectively. The different uptake mechanisms support the concept
about two independent DC differentiation pathways (Caux et al, 1996),
which is probably also reflected at the level of antigen uptake. Both
uptake mechanisms are known to drive towards a similar Ag processing
compartment (Sallusto et al, 1995). Accordingly, the endo-lysosomal
vesicles, where processing and antigen loading takes place, were
identical in both Langerhans cells and DDC. These vesicles displayed
lamellar or multivesicular substructures, characteristic for so-called
MIIC, and have been proposed as the major antigen processing and
loading site in DC (Nijman et al, 1995). We did not directly
address the question of whether those compartments are identical to
multivesicular or multilaminar MHC class II enriched compartments,
although the ultramorphology of the compartments concentrating TT
suggests their presence also in DDC.
To ensure that the immunogenic TT peptides, loaded onto MHC
molecules, are derived from intracellular processing of TT and not
from processing by exogenous proteases in the culture medium, we
took advantage of the fact that antigen processing requires an acidic
lysosomal compartment. TT pulsing of Langerhans cells and DDC in
the presence of chloroquine, which elevates the pH in lysosomal
compartments and blocks processing of TT protein, resulted in signific-
ant reduction of TT specific T cell proliferation. In contrast, TT
peptide induced T cell proliferation, which is not dependent on
intracellular processing, was not significantly inhibited by chloroquine.
A relationship between the maturational state of DC and their ability
to process complex polypeptides such as TT has been mainly shown
for mouse Langerhans cells (Schuler and Steinman, 1985; Romani et al,
1989a) and was later also suggested for human Langerhans cells (Romani
et al, 1989b; Teunissen et al, 1990); however, efficient presentation of
TT by human in vitro generated DC (Sallusto and Lanzavecchia, 1994),
as well as human mature cultured Langerhans cells (Cohen and Katz,
1992), has been demonstrated. In this study, dependence of the
maturational state of DDC on efficiency of antigen processing and
presentation could not be investigated due to a lack of an appropriate
isolation method for ‘‘fresh,’’ immature DDC. The maturational status
of the DDC preparation used here has been extensively investigated
(Nestle et al, 1993). The high surface expression of CD80, CD86,
ICAM-1, CD83 (HB15), and MHC class II molecules, as well as the
potent activation of allogeneic T cells, indicates a mature state of the
DDC preparation used in this study. DDC were as efficient as
Langerhans cells at presenting TT to autologous, resting CD4 positive
T cells and were 5–10 times more potent than highly enriched plastic
adherent monocytes. Furthermore, as few as 50 DDC induced a
significant TT specific T cell proliferation.
DDC express high levels of MHC class II molecules and costimulatory
molecules such as CD80 and C86 in a homogenous manner (Nestle
et al, 1993). Strong surface expression of CD1a is considered a
phenotypic hallmark of human Langerhans cells. Because a minor
subpopulation (10–15%) of DDC expresses low levels of CD1a (Nestle
et al, 1993), we addressed the question of whether the minor CD1a1
subpopulation accounts for the potent APC capacity of DDC. There-
fore, DDC were differentially sorted in CD1a1 and CD1a– cells and
tested for the induction of TT specific T cell proliferation. On a per
cell basis, CD1a1 as well as CD1a– subpopulations were equally potent
as unsorted DDC in the induction of TT driven T cell proliferation.
This is in contrast to a published work investigating fresh dermal cell
suspensions, where, by indirect reasoning, the major antigen-presenting
cell function for allogeneic T cell proliferations was found mainly in
the CD1a population (Sepulveda-Merrill et al, 1994). It is therefore
important to mention that, for reasons of cell purity and to assess TT
specific T cell proliferation on a per cell basis, our data were obtained
with highly enriched cultured DDC that could account for the
different findings.
In summary, we have provided evidence that DDC are as efficient
as Langerhans cells in the internalization, processing, and presentation
of soluble protein antigens such as TT to resting T helper cells.
Therefore, DDC in their strategic perivascular location in human
dermis may play an important role in the activation of skin seeking T
cells in response to soluble protein antigens.
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